Kratos insiders made 69 sales in six months and not one purchase

Sixty-nine insider trades, not one buy

Kratos Defense▼−2.42% — Kratos Defense, down 2.42 percent today & Security Solutions (NASDAQ: KTOS), the San Diego contractor behind the Valkyrie combat drone, has spent six months writing a one-sided ledger: 69 open-market insider trades, every one a sale and not a single purchase, a pace the SEC's Form 4 filing log↗ confirms with a new notice every few days since May ¹².

CEO Eric DeMarco's four sales moved 300,000 shares for an estimated $19.3 million, about $64 a share on average; CFO Deanna Lund sold 29,000 shares across 14 sales ¹. The dated prints: division president Steven Fendley sold at $56.16 on August 24, director Scot Jarvis at $63.50 on August 18 ³.

The stock closed November 12 at $34.75, down 5.3% on the day↗ and about 43% below its 200-day average ³. Sixty-nine sales in six months, and the only named buyer this week was Cathie Wood.

The one big buyer is Cathie Wood

On November 11, ARK Innovation bought 66,183 shares and ARK Autonomous Technology & Robotics added 19,020, more than $3 million combined, an average above $35 ⁴⁵. ARK had also bought on November 6, the day after earnings, across three funds including ARK Space & Defense ⁶. What the funds hold: third-quarter revenue of $471.8 million, up 35.7%↗, $1.037 billion of bookings at a 2.2-to-1 book-to-bill, a record $2.65 billion backlog, and 2027 guidance of $2.1 to $2.2 billion ⁷. The stock is still down about 53% this year ⁴.

The growth still burns cash

The same quarter lost $4.9 million at the operating line and used $29.4 million of free cash flow after $30.2 million of capital spending ⁷. Kratos guides to a full-year 2026 cash use of $110 to $120 million and does not expect to turn cash-flow positive until 2029 ⁷⁸. Unmanned Systems, the segment that builds Valkyrie, shrank to $74.6 million and booked a 0.8-to-1 book-to-bill ⁷. BTIG cut its target from $104 to $65, KeyBanc from $130 to $75 and Guggenheim from $74 to $67, yet the consensus sits at $77.40, more than double the price ³⁹.

December 11 and late February decide what comes next

The insiders' defense is on the record: Fendley's sale ran under a 10b5-1 plan, a selling schedule committed in advance, and he still held 288,111 shares afterward; no filing states intent ³. The filings do state arithmetic: nobody on the roster bought at $35 ⁷. The same tell ran through NuScale in October ⁷. What moves the stock next is dated: the federal continuing resolution that restricts new program starts runs at least to December 11, and Kratos says it must reassess its 2027 forecast if it stretches past March 31 ⁷. Fourth-quarter results land in late February ⁷.